Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 5801209, 8 pages
https://doi.org/10.1155/2018/5801209
Review Article

Reactive Oxygen Species-Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer

1Department of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430071, China
2Department of Clinical Oncology, First Affiliated Hospital, Medical School of Xi’an Jiaotong University, Xi’an, Shanxi 710061, China
3School of Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA
4Department of Hematology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430071, China
5Department of Clinical Pharmacy, Wuhan Union Hospital, Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China

Correspondence should be addressed to Yongchang Wei; nc.ude.uhw@gnahcgnoyiew

Received 7 October 2017; Revised 30 January 2018; Accepted 26 February 2018; Published 27 March 2018

Academic Editor: Karin Thevissen

Copyright © 2018 Huifeng Gu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Chen, R. Zheng, P. D. Baade et al., “Cancer statistics in China, 2015,” CA: A Cancer Journal for Clinicians, vol. 66, no. 2, pp. 115–132, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: a Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Ng and P. Lee, “The role of radiotherapy in localized esophageal and gastric cancer,” Hematology/Oncology Clinics of North America, vol. 31, no. 3, pp. 453–468, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. H. H. Hartgrink, E. P. Jansen, N. C. van Grieken, and C. J. van de Velde, “Gastric cancer,” The Lancet, vol. 374, no. 9688, pp. 477–490, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Szumiel, “Ionizing radiation-induced oxidative stress, epigenetic changes and genomic instability: the pivotal role of mitochondria,” International Journal of Radiation Biology, vol. 91, no. 1, pp. 1–12, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Zhang, D. N. Tripathi, J. Jing et al., “ATM functions at the peroxisome to induce pexophagy in response to ROS,” Nature Cell Biology, vol. 17, no. 10, pp. 1259–1269, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Huang, F. Wang-Johanning, F. Zhou, H. Kallon, and Y. Wei, “MicroRNAs serve as a bridge between oxidative stress and gastric cancer (review),” International Journal of Oncology, vol. 49, no. 5, pp. 1791–1800, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Huang, F. Zhou, F. Wang-Johanning, K. Nan, and Y. Wei, “Depression accelerates the development of gastric cancer through reactive oxygen species-activated ABL1 (review),” Oncology Reports, vol. 36, no. 5, pp. 2435–2443, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Tu, H. Sun, Y. Lin et al., “Oxidative stress upregulates PDCD4 expression in patients with gastric cancer via miR-21,” Current Pharmaceutical Design, vol. 20, no. 11, pp. 1917–1923, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Bao, Q. Wu, R. E. McLendon et al., “Glioma stem cells promote radioresistance by preferential activation of the DNA damage response,” Nature, vol. 444, no. 7120, pp. 756–760, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Triner and Y. M. Shah, “Hypoxia-inducible factors: a central link between inflammation and cancer,” The Journal of Clinical Investigation, vol. 126, no. 10, pp. 3689–3698, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Le Caër, “Water radiolysis: influence of oxide surfaces on H2 production under ionizing radiation,” Water, vol. 3, no. 1, pp. 235–253, 2011. View at Publisher · View at Google Scholar
  13. J. Ichikawa, D. Tsuchimoto, S. Oka et al., “Oxidation of mitochondrial deoxynucleotide pools by exposure to sodium nitroprusside induces cell death,” DNA Repair, vol. 7, no. 3, pp. 418–430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. H. E. Barker, J. T. Paget, A. A. Khan, and K. J. Harrington, “The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence,” Nature Reviews Cancer, vol. 15, no. 7, pp. 409–425, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Diehn, R. W. Cho, N. A. Lobo et al., “Association of reactive oxygen species levels and radioresistance in cancer stem cells,” Nature, vol. 458, no. 7239, pp. 780–783, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. I. Diakos, K. A. Charles, D. C. McMillan, and S. J. Clarke, “Cancer-related inflammation and treatment effectiveness,” The Lancet Oncology, vol. 15, no. 11, pp. e493–e503, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Bickelhaupt, C. Erbel, C. Timke et al., “Effects of CTGF blockade on attenuation and reversal of radiation-induced pulmonary fibrosis,” Journal of the National Cancer Institute, vol. 109, no. 8, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Rey, L. Schito, M. Koritzinsky, and B. G. Wouters, “Molecular targeting of hypoxia in radiotherapy,” Advanced Drug Delivery Reviews, vol. 109, pp. 45–62, 2017. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Thienpont, J. Steinbacher, H. Zhao et al., “Tumour hypoxia causes DNA hypermethylation by reducing TET activity,” Nature, vol. 537, no. 7618, pp. 63–68, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Klug, H. Prakash, P. E. Huber et al., “Low-dose irradiation programs macrophage differentiation to an iNOS+/M1 phenotype that orchestrates effective T cell immunotherapy,” Cancer Cell, vol. 24, no. 5, pp. 589–602, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. F. G. Herrera, J. Bourhis, and G. Coukos, “Radiotherapy combination opportunities leveraging immunity for the next oncology practice,” CA: A Cancer Journal for Clinicians, vol. 67, no. 1, pp. 65–85, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Blankenstein, P. G. Coulie, E. Gilboa, and E. M. Jaffee, “The determinants of tumour immunogenicity,” Nature Reviews. Cancer, vol. 12, no. 4, pp. 307–313, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Prasad, S. C. Gupta, and A. K. Tyagi, “Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals,” Cancer Letters, vol. 387, pp. 95–105, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. H. Hsu, C. C. Wei, D. B. Shieh, C. H. Chan, and M. S. Chang, “Anti-IL-20 monoclonal antibody alleviates inflammation in oral cancer and suppresses tumor growth,” Molecular Cancer Research, vol. 10, no. 11, pp. 1430–1439, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Monkkonen and J. Debnath, “Inflammatory signaling cascades and autophagy in cancer,” Autophagy, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  26. H. Wang, L. Wang, N. L. Li et al., “Subanesthetic isoflurane reduces zymosan-induced inflammation in murine Kupffer cells by inhibiting ROS-activated p38 MAPK/NF-ĸB signaling,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 851692, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Blaser, C. Dostert, T. W. Mak, and D. Brenner, “TNF and ROS crosstalk in inflammation,” Trends in Cell Biology, vol. 26, no. 4, pp. 249–261, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Petanidis, E. Kioseoglou, K. Domvri et al., “In vitro and ex vivo vanadium antitumor activity in (TGF-β)-induced EMT. Synergistic activity with carboplatin and correlation with tumor metastasis in cancer patients,” The International Journal of Biochemistry & Cell Biology, vol. 74, pp. 121–134, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Valavanidis, T. Vlachogianni, K. Fiotakis, and S. Loridas, “Pulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms,” International Journal of Environmental Research and Public Health, vol. 10, no. 9, pp. 3886–3907, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Oruqaj, S. Karnati, V. Vijayan et al., “Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 16, pp. E2048–E2057, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Kaur, V. Borse, S. Sheth et al., “Adenosine A1 receptor protects against cisplatin ototoxicity by suppressing the NOX3/STAT1 inflammatory pathway in the cochlea,” The Journal of Neuroscience, vol. 36, no. 14, pp. 3962–3977, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. C. Wei, F. L. Zhou, D. L. He et al., “Oxidative stress in depressive patients with gastric adenocarcinoma,” International Journal of Neuropsychopharmacology, vol. 12, no. 8, pp. 1089–1096, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Hayakawa, H. Ariyama, J. Stancikova et al., “Mist1 expressing gastric stem cells maintain the normal and neoplastic gastric epithelium and are supported by a perivascular stem cell niche,” Cancer Cell, vol. 28, no. 6, pp. 800–814, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. J. C. Santos, E. Carrasco-Garcia, M. Garcia-Puga et al., “SOX9 elevation acts with canonical WNT signaling to drive gastric cancer progression,” Cancer Research, vol. 76, no. 22, pp. 6735–6746, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Liu, M. L. Burness, R. Martin-Trevino et al., “RAD51 mediates resistance of cancer stem cells to PARP inhibition in triple-negative breast cancer,” Clinical Cancer Research, vol. 23, no. 2, pp. 514–522, 2017. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Ogrunc, R. I. Martinez-Zamudio, P. B. Sadoun et al., “USP1 regulates cellular senescence by controlling genomic integrity,” Cell Reports, vol. 15, no. 7, pp. 1401–1411, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Natarajan, F. Begum, J. Gim et al., “High mobility group A2 protects cancer cells against telomere dysfunction,” Oncotarget, vol. 7, no. 11, pp. 12761–12782, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Iacobucci, A. G. Di Rora, M. V. Falzacappa et al., “In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia,” Journal of Hematology & Oncology, vol. 8, no. 1, p. 125, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Zhang, Y. Wei, L. Wang et al., “ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1,” Nature Cell Biology, vol. 16, no. 9, pp. 864–875, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. W. J. Wang, S. P. Wu, J. B. Liu et al., “MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells,” Cancer Research, vol. 73, no. 3, pp. 1219–1231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Shimura, N. Noma, T. Oikawa et al., “Activation of the AKT/cyclin D1/Cdk4 survival signaling pathway in radioresistant cancer stem cells,” Oncogene, vol. 1, no. 6, article e12, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Mayr, A. Wagner, M. Loeffelberger et al., “The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells,” Oncotarget, vol. 7, no. 1, pp. 745–758, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Saygin, A. Wiechert, V. S. Rao et al., “CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors,” The Journal of Experimental Medicine, vol. 214, no. 9, pp. 2715–2732, 2017. View at Publisher · View at Google Scholar · View at Scopus
  44. B. C. Lu, J. Li, W. F. Yu, G. Z. Zhang, H. M. Wang, and H. M. Ma, “Elevated expression of Nrf2 mediates multidrug resistance in CD133+ head and neck squamous cell carcinoma stem cells,” Oncology Letters, vol. 12, no. 6, pp. 4333–4338, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Sparaneo, F. P. Fabrizio, and L. A. Muscarella, “Nrf2 and notch signaling in lung cancer: near the crossroad,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 7316492, 17 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Mitsuishi, H. Motohashi, and M. Yamamoto, “The Keap1–Nrf2 system in cancers: stress response and anabolic metabolism,” Frontiers in Oncology, vol. 2, p. 200, 2012. View at Publisher · View at Google Scholar
  47. R. Wang, J. Wei, S. Zhang et al., “Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer,” Oncotarget, vol. 7, no. 52, pp. 86816–86828, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Perkins, K. J. Nelson, D. Parsonage, L. B. Poole, and P. A. Karplus, “Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling,” Trends in Biochemical Sciences, vol. 40, no. 8, pp. 435–445, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. V. Kumar and D. I. Gabrilovich, “Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment,” Immunology, vol. 143, no. 4, pp. 512–519, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Bensimon, D. Biard, V. Paget et al., “Forced extinction of CD24 stem-like breast cancer marker alone promotes radiation resistance through the control of oxidative stress,” Molecular Carcinogenesis, vol. 55, no. 3, pp. 245–254, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. I. Skvortsova, P. Debbage, V. Kumar, and S. Skvortsov, “Radiation resistance: cancer stem cells (CSCs) and their enigmatic pro-survival signaling,” Seminars in Cancer Biology, vol. 35, pp. 39–44, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Krause, A. Dubrovska, A. Linge, and M. Baumann, “Cancer stem cells: radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments,” Advanced Drug Delivery Reviews, vol. 109, pp. 63–73, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. M. E. Prince, R. Sivanandan, A. Kaczorowski et al., “Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 3, pp. 973–978, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Zoller, “CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?” Nature Reviews Cancer, vol. 11, no. 4, pp. 254–267, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Kinugasa, K. A. Whelan, K. Tanaka et al., “Mitochondrial SOD2 regulates epithelial–mesenchymal transition and cell populations defined by differential CD44 expression,” Oncogene, vol. 34, no. 41, pp. 5229–5239, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. V. J. Findlay, C. Wang, D. K. Watson, and E. R. Camp, “Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer,” Cancer Gene Therapy, vol. 21, no. 5, pp. 181–187, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Csermely, J. Hodsagi, T. Korcsmaros et al., “Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential mechanism: network models, novel therapeutic target strategies, and the contributions of hypoxia, inflammation and cellular senescence,” Seminars in Cancer Biology, vol. 30, pp. 42–51, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. P. H. Nguyen, J. Giraud, L. Chambonnier et al., “Characterization of biomarkers of tumorigenic and chemoresistant cancer stem cells in human gastric carcinoma,” Clinical Cancer Research, vol. 23, no. 6, pp. 1586–1597, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Nakajima and M. Kitamura, “Bidirectional regulation of NF-κB by reactive oxygen species: a role of unfolded protein response,” Free Radical Biology and Medicine, vol. 65, pp. 162–174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Capece, D. Verzella, A. Tessitore, E. Alesse, C. Capalbo, and F. Zazzeroni, “Cancer secretome and inflammation: the bright and the dark sides of NF-ĸB,” Seminars in Cell & Developmental Biology, 2017. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Bharti, G. Dey, and M. Mandal, “Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: a snapshot of IL-6 mediated involvement,” Cancer Letters, vol. 375, no. 1, pp. 51–61, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Middleton, J. Jones, Z. Lwin, and J. I. Coward, “Interleukin-6: an angiogenic target in solid tumours,” Critical Reviews in Oncology/Hematology, vol. 89, no. 1, pp. 129–139, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Cohen, I. Bruchim, D. Graiver et al., “Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2,” Journal of Molecular Medicine, vol. 91, no. 3, pp. 357–368, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. K. Storch, E. Dickreuter, A. Artati, J. Adamski, and N. Cordes, “BEMER electromagnetic field therapy reduces cancer cell radioresistance by enhanced ROS formation and induced DNA damage,” PLoS One, vol. 11, no. 12, article e0167931, 2016. View at Publisher · View at Google Scholar · View at Scopus
  65. B. Yu, T. Liu, Y. Du, Z. Luo, W. Zheng, and T. Chen, “X-ray-responsive selenium nanoparticles for enhanced cancer chemo-radiotherapy,” Colloids and Surfaces B: Biointerfaces, vol. 139, pp. 180–189, 2016. View at Publisher · View at Google Scholar · View at Scopus
  66. G. Dong, Q. Chen, F. Jiang et al., “Diisopropylamine dichloroacetate enhances radiosensitization in esophageal squamous cell carcinoma by increasing mitochondria-derived reactive oxygen species levels,” Oncotarget, vol. 7, no. 42, pp. 68170–68178, 2016. View at Publisher · View at Google Scholar
  67. S. Karthik, R. Sankar, K. Varunkumar, C. Anusha, and V. Ravikumar, “Blocking NF-κB sensitizes non-small cell lung cancer cells to histone deacetylase inhibitor induced extrinsic apoptosis through generation of reactive oxygen species,” Biomedicine & Pharmacotherapy, vol. 69, pp. 337–344, 2015. View at Publisher · View at Google Scholar · View at Scopus
  68. P. Perez-Galan, G. Roue, N. Villamor, E. Montserrat, E. Campo, and D. Colomer, “The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status,” Blood, vol. 107, no. 1, pp. 257–264, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. M. W. Sung, D. Y. Lee, S. W. Park et al., “Celecoxib enhances the inhibitory effect of 5-FU on human squamous cell carcinoma proliferation by ROS production,” The Laryngoscope, vol. 127, no. 4, pp. E117–E123, 2017. View at Publisher · View at Google Scholar · View at Scopus
  70. P. Sonkusre and S. S. Cameotra, “Biogenic selenium nanoparticles induce ROS-mediated necroptosis in PC-3 cancer cells through TNF activation,” Journal of Nanobiotechnology, vol. 15, no. 1, p. 43, 2017. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Pajic, D. Froio, S. Daly et al., “miR-139-5p modulates radiotherapy resistance in breast cancer by repressing multiple gene networks of DNA repair and ROS defense,” Cancer Research, vol. 78, no. 2, pp. 501–515, 2018. View at Publisher · View at Google Scholar
  72. Y. Yang, M. Jiang, J. Hu et al., “Enhancement of radiation effects by ursolic acid in BGC-823 human adenocarcinoma gastric cancer cell line,” PLoS One, vol. 10, no. 7, article e0133169, 2015. View at Publisher · View at Google Scholar · View at Scopus
  73. F. B. Cui, Q. Liu, R. T. Li et al., “Enhancement of radiotherapy efficacy by miR-200c-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer cells,” International Journal of Nanomedicine, vol. 9, pp. 2345–2358, 2014. View at Publisher · View at Google Scholar · View at Scopus